RAYDERM HYDRATING TONER- glycerin toner liquid 
VORY MEDICAL. Inc

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

ACTIVE INGREDIENT

Glycerin (2.5%) - Skin Protectact

INACTIVE INGREDIENT

Purified Water, Propanediol, Dipropylene, Methyl Gluceth-20, Glycereth-26, Glycerin, Pentylene Glycol, Betaine, C12-14 Pareth-12, Trehalose, Salvia Hispanica Seed Extract, Centella Asiatica Extract, Houttuynia Cordata Extract, Polyquaternium-51, Sodium Citrate, Sea Buckthorn Water, Butylene Glycol, Ethylhexylglycerin, 1,2-Hexanediol, Citric Acid, Sodium Palmitoyl Proline, Nymphaea Tetragona Flower Extract, Green tea Extract, Black Rice Bran Extract, Cucumber Extract, Caprylyl Glycol, Fragrance

PURPOSE

Skin Protectact

WARNINGS

Precautions of Use
1) If rash, redness, swelling, itching or other adverse reactions occur as a result of exposure to sunlight during or after use, consult a doctor / specialist.
2) Refrain from using on wound sites.
3) Storage and handling precautions:
i) Keep out of reach of children.
ii) Keep away from direct sunlight

KEEP OUT OF REACH OF CHILDREN

INDICATIONS & USAGE

Apply the toner on the skin and spread evenly.

DOSAGE & ADMINISTRATION

Apply the toner on the skin and spread evenly.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image description

RAYDERM HYDRATING TONER 
glycerin toner liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72543-004
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
glycerin (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) glycerin6.25 g  in 250 mL
Inactive Ingredients
Ingredient NameStrength
water (UNII: 059QF0KO0R)  
PROPANEDIOL (UNII: 5965N8W85T)  
DIPROPYLENE GLYCOL (UNII: E107L85C40)  
METHYL GLUCETH-20 (UNII: J3QD0LD11P)  
GLYCERETH-26 (UNII: NNE56F2N14)  
PENTYLENE GLYCOL (UNII: 50C1307PZG)  
BETAINE (UNII: 3SCV180C9W)  
C12-14 PARETH-12 (UNII: M0LJS773XW)  
TREHALOSE (UNII: B8WCK70T7I)  
SALVIA HISPANICA SEED (UNII: NU0OLX06F8)  
CENTELLA ASIATICA (UNII: 7M867G6T1U)  
POLYQUATERNIUM-51 (2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE/N-BUTYL METHACRYLATE; 3:7) (UNII: EL9825H96J)  
SODIUM CITRATE (UNII: 1Q73Q2JULR)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
1,2-HEXANEDIOL (UNII: TR046Y3K1G)  
SODIUM PALMITOYL PROLINE (UNII: 64L053FRFO)  
NYMPHAEA ALBA FLOWER (UNII: 40KQ7Q535O)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72543-004-01250 mL in 1 PACKAGE; Type 0: Not a Combination Product10/11/2018
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other10/11/2018
Labeler - VORY MEDICAL. Inc (694721104)
Registrant - VORY MEDICAL. Inc (694721104)
Establishment
NameAddressID/FEIBusiness Operations
VORY MEDICAL. Inc694721104manufacture(72543-004)

Revised: 10/2018
Document Id: 80cc59a9-01ab-4cdd-9f1c-6eb14676fe51
Set id: abc43916-710b-4e18-ada2-fa15cf68f28e
Version: 1
Effective Time: 20181011
 
VORY MEDICAL. Inc